| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/04/2026 | ±3.9% | +3.7% | over-priced |
| 04/28/2026 | ±1.8% | +0.2% | over-priced |
| 02/12/2026 | ±2.0% | +0.6% | over-priced |
| 10/30/2025 | ±2.4% | +3.0% | under-priced |
| 08/01/2025 | ±1.6% | +4.8% | under-priced |
| 04/22/2025 | ±2.5% | -1.5% | over-priced |
| 02/13/2025 | ±1.6% | +1.1% | over-priced |
| 10/22/2024 | ±1.7% | -4.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.04 | $4.2B | $345M |
| Q1 FY2026 | $2.00 | $4.2B | $665M |
| Q4 FY2025 | $1.50 | $4.1B | $499M |
| Q3 FY2025 | $1.34 | $4.2B | $446M |
Kimberly-Clark Corporation Common Stock (KMB) reports in 8 days, with the next report estimated for 11/04/2026. Across the last 8 reports, options priced an average ±2.2% earnings move while the stock actually moved 2.4% on average — the market has been roughly fair on KMB's earnings risk. Fundamentals into the print: EPS down 32.0% year-over-year, revenue up 0.6%. QuantLogix's live 5-factor engine currently reads KMB as a buy at 68/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →